晶癖測定に基づく結晶性医薬品の偏光顕微鏡分析微細結晶の晶癖, 粒度, 比表面積等の迅速測定を目的として
スポンサーリンク
概要
- 論文の詳細を見る
In 1939 the author reported the results of measured refractive indices of about a hundred crystalline drugs listed in [JP V] at the Takeda Reseach Laboratory using a Leitz PM polarizing microscope and newly developed immersion oils. When the author had reopened the study of crystalline drugs using a polarizing microscope at the Kobe-Gakuin University starting from 1975 one of the main purposes was to clarify the relation between crystal habits and refractive indices. It had been found that in most cases of crystal habits refractive indices were uniquely measured from a predominant pair of faces forming superior the habit, and they were called as "key refractive indices". The author and his co-workers tried to investigate the possibility of measuring the key refractive indices widely from all the obtainable crystalline drugs listed in the [JP X] or [JP XI], co-operating with the Pharmacy of Kobe University Hospital. Thus, more than 170 kinds of crystalline drugs were tested for their key refractive indices and found that they were measured from about 60-70% of tested drugs. It was also clarified that the difference of 2 key refractive indices, (n_2-n_1), the birefringence of the section, was also an unique invariable number for the habit, and it played an important role not only for the graphic representation of log(n_2-n_1), abscissa, against (n_1,n_2), ordinate, for the sake of an analytical purpose but also to measure a thickness of a section (habit) using a retardation color. Then, it had been cleared that the similarity of crystal habits in the microscopic field was based on the facts of measuring the same key refractive indices, and the author had developed a chart for measuring key refractive indices as well as producing a 3 dimensional orthographic projection of a crystal habit simultaneously applying a thickness measuring method using a birefringence. Finally 3 dimensional parameter a, b, c of a crystal habit and "habit coefficients" T : √<ab>/c and L : b/c were determined from the orthographic projection. In conclusion using the similarity in crystal habits the distributions of particle sizes and specific surface areas of all the crystals in the microscopic field had been calculated by a personal computer putting in necessary habit coefficients and obtained data of parameter b. The relation between 2 dispersions of perticle sizes in log (V) and specific surface areas in log (SSA) were shown under the rectangular coordinates log (V) on the abscissa and log (SSA) on the ordinate, where the loci of log (SSA) formed simple striped pattern composed of parallel straight lines depending on habit coefficients. It would be possible to estimate the value of a specific surface area of any crystalline substance by plotting the value of log (V) on the straight line of a locus of log (SSA) having the same habit coefficients.
- 公益社団法人日本薬学会の論文
- 1997-11-01
著者
関連論文
- 結晶性医薬品の結晶形態と晶癖の研究(第2報)アモバルビタール, バルビタール及び塩酸エフェドリン
- 偏光顕微鏡による結晶性医薬品の研究(第16報)晶癖の相似性を利用する結晶性医薬品の粒度及び比表面積分布曲線の作成
- 偏光顕微鏡による結晶性医薬品の研究(第15報)写真法を用いる浸液法による必要な結晶特性の定常的測定(その1)
- 結晶性医薬品の結晶形態と晶癖の研究(第3報)スルファメチゾール, レボドパ及びフェノバルビタール
- 結晶性医薬品の結晶形態と晶癖の研究(第1報)フェニトイン
- 偏光顕微鏡による結晶性医薬品の研究(第11報)散剤中の主薬の粒度分析, フェニトイン10倍散の場合
- 偏光顕微鏡による結晶性医薬品の研究(第10報) : フェニトイン粉末の粒度分析
- 13. ビタミンB_1製剤の安定性を確保した渡辺らの初期の研究と, John J. Windheuserらのその後の動力学的研究について
- 1. 葉酸の晶癖分析とその溶状との係わり
- 晶癖測定に基づく結晶性医薬品の偏光顕微鏡分析微細結晶の晶癖, 粒度, 比表面積等の迅速測定を目的として
- 6.結晶性ビタミンのPolarizing Photo-micmscopy : ビタミンB研究委員会 第347回会議研究発表要旨
- 葉酸結晶の粒度分布と比表面積の動向 : ビタミンB研究委員会 : 第300回会議研究発表要旨
- 4.難溶性ビタミン類の生物学的利用能に関係する結晶々癖の定量的測定(第293回会議研究発表要旨,ビタミンB研究委員会)
- Study of Crystalline Drugs by Means of a Polarizing Microscope. VIII. : A Simple and Rapid Method to Measure the Thickness of a Crystalline Drug and Its Application to the Quality Testing of Poorly Soluble Drugs
- 偏光顕微鏡による結晶性医薬品の研究-9-「日局10」収載結晶性薬品の分析,同定及び厚さの測定などが同時にできるチャ-トの作成